|
1
|
Jefferies JL and Towbin JA: Dilated
cardiomyopathy. Lancet. 375:752–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schultheiss HP, Fairweather D, Caforio
ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A,
Mazzanti A, McMurray J and Priori SG: Dilated cardiomyopathy. Nat
Rev Dis Primers. 5:322019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cutler MJ, Jeyaraj D and Rosenbaum DS:
Cardiac electrical remodeling in health and disease. Trends
Pharmacol Sci. 32:174–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mann DL: Inflammatory mediators and the
failing heart: Past, present, and the foreseeable future. Circ Res.
91:988–998. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crow MT, Mani K, Nam YJ and Kitsis RN: The
mitochondrial death pathway and cardiac myocyte apoptosis. Circ
Res. 95:957–970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hikoso S, Ikeda Y, Yamaguchi O, Takeda T,
Higuchi Y, Hirotani S, Kashiwase K, Yamada M, Asahi M, Matsumura Y,
et al: Progression of heart failure was suppressed by inhibition of
apoptosis signal-regulating kinase 1 via transcoronary gene
transfer. J Am Coll Cardiol. 50:453–462. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Q, Zhou HJ, Zhang H, Huang Y,
Hinojosa-Kirschenbaum F, Fan P, Yao L, Belardinelli L, Tellides G,
Giordano FJ, et al: Thioredoxin-2 inhibits mitochondrial reactive
oxygen species generation and apoptosis stress kinase-1 activity to
maintain cardiac function. Circulation. 131:1082–1097. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maejima Y, Kyoi S, Zhai P, Liu T, Li H,
Ivessa A, Sciarretta S, Del Re DP, Zablocki DK, Hsu CP, et al: Mst1
inhibits autophagy by promoting the interaction between Beclin1 and
Bcl-2. Nat Med. 19:1478–1488. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller EJ, Li J, Leng L, McDonald C,
Atsumi T, Bucala R and Young LH: Macrophage migration inhibitory
factor stimulates AMP-activated protein kinase in the ischaemic
heart. Nature. 451:578–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong YJ, Kim TK, Hong D, Park CH, Yoo SJ,
Wickum ME, Hur J, Lee HJ, Kim YJ, Suh YJ, et al: Myocardial
characterization using dual-energy CT in doxorubicin-induced DCM:
Comparison with CMR T1-mapping and histology in a rabbit model.
JACC Cardiovasc Imaging. 9:836–845. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marechal X, Montaigne D, Marciniak C,
Marchetti P, Hassoun SM, Beauvillain JC, Lancel S and Neviere R:
Doxorubicin-induced cardiac dysfunction is attenuated by
ciclosporin treatment in mice through improvements in mitochondrial
bioenergetics. Clin Sci (Lond). 121:405–413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lefebvre V: The SoxD transcription
factors-Sox5, Sox6, and Sox13-are key cell fate modulators. Int J
Biochem Cell Biol. 42:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zou H, Wang S, Wang S, Wu H, Yu J, Chen Q,
Cui W, Yuan Y, Wen X, He J, et al: SOX5 interacts with YAP1 to
drive malignant potential of non-small cell lung cancer cells. Am J
Cancer Res. 8:866–878. 2018.PubMed/NCBI
|
|
14
|
Sun C, Ban Y, Wang K, Sun Y and Zhao Z:
SOX5 promotes breast cancer proliferation and invasion by
transactivation of EZH2. Oncol Lett. 17:2754–2762. 2019.PubMed/NCBI
|
|
15
|
Ueda R, Yoshida K, Kawase T, Kawakami Y
and Toda M: Preferential expression and frequent IgG responses of a
tumor antigen, SOX5, in glioma patients. Int J Cancer.
120:1704–1711. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You J, Zhao Q, Fan X and Wang J: SOX5
promotes cell invasion and metastasis via activation of
Twist-mediated epithelial-mesenchymal transition in gastric cancer.
Onco Targets Ther. 12:2465–2476. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hattori T, Coustry F, Stephens S,
Eberspaecher H, Takigawa M, Yasuda H and de Crombrugghe B:
Transcriptional regulation of chondrogenesis by coactivator Tip60
via chromatin association with Sox9 and Sox5. Nucleic Acids Res.
36:3011–3024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pfeufer A, van Noord C, Marciante KD,
Arking DE, Larson MG, Smith AV, Tarasov KV, Müller M, Sotoodehnia
N, Sinner MF, et al: Genome-wide association study of PR interval.
Nat Genet. 42:153–159. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eijgelsheim M, Newton-Cheh C, Sotoodehnia
N, de Bakker PI, Müller M, Morrison AC, Smith AV, Isaacs A, Sanna
S, Dörr M, et al: Genome-wide association analysis identifies
multiple loci related to resting heart rate. Hum Mol Genet.
19:3885–3894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Olesen MS, Holst AG, Jabbari J, Nielsen
JB, Christophersen IE, Sajadieh A, Haunsø S and Svendsen JH:
Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated
with onset of lone atrial fibrillation before the age of 40 years.
Can J Cardiol. 28:191–195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Della-Morte D, Beecham A, Rundek T, Wang
L, McClendon MS, Slifer S, Blanton SH, Di Tullio MR and Sacco RL: A
follow-up study for left ventricular mass on chromosome 12p11
identifies potential candidate genes. BMC Med Genet. 12:1002011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li A, Ahsen OO, Liu JJ, Du C, McKee ML,
Yang Y, Wasco W, Newton-Cheh CH, O'Donnell CJ, Fujimoto JG, et al:
Silencing of the Drosophila ortholog of SOX5 in heart leads to
cardiac dysfunction as detected by optical coherence tomography.
Hum Mol Genet. 22:3798–3806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Halliday BP, Cleland JGF, Goldberger JJ
and Prasad SK: Personalizing risk stratification for sudden death
in dilated cardiomyopathy: The past, present, and future.
Circulation. 136:215–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Zhang XL, Li XF, Tang YC and Zhao
X: miR-212-3p reduced proliferation, and promoted apoptosis of
fibroblast-like synoviocytes via down-regulating SOX5 in rheumatoid
arthritis. Eur Rev Med Pharmacol Sci. 22:461–471. 2018.PubMed/NCBI
|
|
25
|
Li G, Wang K, Wang J, Qin S, Sun X and Ren
H: miR-497-5p inhibits tumor cell growth and invasion by targeting
SOX5 in non-small-cell lung cancer. J Cell Biochem.
120:10587–10595. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Veronique MW, Critcher R, Ashworth A and
Goodfellow PN: Cloning and characterization of SOX5, a new member
of the human SOX gene family. Genomics. 36:354–358. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu F, Liu X, Yang Y, Sun Z, Deng S, Jiang
Z, Li W and Wu F: NEAT1/miR-193a-3p/SOX5 axis regulates cartilage
matrix degradation in human osteoarthritis. Cell Biol Int.
44:947–957. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Axelsson AS, Mahdi T, Nenonen HA, Singh T,
Hänzelmann S, Wendt A, Bagge A, Reinbothe TM, Millstein J, Yang X,
et al: Sox5 regulates beta-cell phenotype and is reduced in type 2
diabetes. Nat Commun. 8:156522017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stolt CC, Lommes P, Hillgartner S and
Wegner M: The transcription factor Sox5 modulates Sox10 function
during melanocyte development. Nucleic Acids Res. 36:5427–5440.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hayward R and David SH: Doxorubicin
Cardiotoxicity in the rat: An in vivo characterization. J Am Assoc
Lab Anim Sci. 46:20–32. 2007.PubMed/NCBI
|
|
31
|
Sun X, Shan A, Wei Z and Xu B: Intravenous
mesenchymal stem cell-derived exosomes ameliorate myocardial
inflammation in the dilated cardiomyopathy. Biochem Biophys Res
Commun. 503:2611–2618. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iwata Y, Ohtake H, Suzuki O, Matsuda J,
Komamura K and Wakabayashi S: Blockade of sarcolemmal TRPV2
accumulation inhibits progression of dilated cardiomyopathy.
Cardiovasc Res. 99:760–768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Japp AG, Gulati A, Cook SA, Cowie MR and
Prasad SK: The diagnosis and evaluation of dilated cardiomyopathy.
J Am Coll Cardiol. 67:2996–3010. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grilo AL and Mantalaris A: Apoptosis: A
mammalian cell bioprocessing perspective. Biotechnol Adv.
37:459–475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kankeu C, Clarke K, Passante E and Huber
HJ: Doxorubicin-induced chronic dilated cardiomyopathy-the
apoptosis hypothesis revisited. J Mol Med (Berl). 95:239–248. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Le Dour C, Macquart C, Sera F, Homma S,
Bonne G, Morrow JP, Worman HJ and Muchir A: Decreased WNT/β-catenin
signalling contributes to the pathogenesis of dilated
cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol
Genet. 26:333–343. 2017.PubMed/NCBI
|
|
37
|
Martinez-Morales PL, Quiroga AC, Barbas JA
and Morales AV: SOX5 controls cell cycle progression in neural
progenitors by interfering with the WNT-beta-catenin pathway. EMBO
Rep. 11:466–472. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li A, Hooli B, Mullin K, Tate RE, Bubnys
A, Kirchner R, Chapman B, Hofmann O, Hide W and Tanzi RE: Silencing
of the Drosophila ortholog of SOX5 leads to abnormal neuronal
development and behavioral impairment. Hum Mol Genet. 26:1472–1482.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
